Eric H. Bjerkholt

2014 - Sunesis Pharmaceuticals

In 2014, Eric H. Bjerkholt earned a total compensation of $1.3M as Executive Vice President, Corporate Development and Finance, Chief Financial Officer and Corporate Secretary at Sunesis Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$117,500
Option Awards$741,762
Salary$390,062
Other$4,306
Total$1,253,630

Bjerkholt received $741.8K in option awards, accounting for 59% of the total pay in 2014.

Bjerkholt also received $117.5K in non-equity incentive plan, $390.1K in salary and $4.3K in other compensation.

Rankings

In 2014, Eric H. Bjerkholt's compensation ranked 6,562nd out of 13,032 executives tracked by ExecPay. In other words, Bjerkholt earned more than 49.6% of executives.

ClassificationRankingPercentile
All
6,562
out of 13,032
50th
Division
Manufacturing
2,395
out of 4,966
52nd
Major group
Chemicals And Allied Products
807
out of 1,686
52nd
Industry group
Drugs
630
out of 1,365
54th
Industry
Pharmaceutical Preparations
481
out of 1,043
54th
Source: SEC filing on April 20, 2017.

Bjerkholt's colleagues

We found one more compensation record of an executive who worked with Eric H. Bjerkholt at Sunesis Pharmaceuticals in 2014.

2014

Daniel Swisher

Sunesis Pharmaceuticals

Chief Executive Officer

News

In-depth

You may also like